Latest Ratios: P/E Ratio -0.3x · EV/EBITDA N/A · ROE -1024.6%. (2020–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $13M | $32M | $271M | $885M | $93M | $181M | — |
| Enterprise Value | $27M | $46M | $309M | $830M | $17M | $186M | — |
| P/E Ratio → | -0.26 | — | — | — | — | 3879.52 | — |
| P/S Ratio | 0.23 | 0.57 | 5.46 | 14.14 | 2.49 | 7.11 | — |
| P/B Ratio | — | — | 20.13 | 7.73 | — | 1.30 | — |
| P/FCF | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.83 | 6.23 | 13.25 | 0.46 | 7.31 | — |
| EV / EBITDA | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 45.3% | 45.3% | 47.6% | 28.2% | 24.3% | 40.2% | 36.8% |
| Operating Margin | -141.7% | -141.7% | -219.7% | -169.9% | -202.4% | -200.4% | -216.3% |
| Net Profit Margin | -87.7% | -87.7% | -277.7% | -214.1% | -204.5% | -183.4% | -205.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | -1024.6% | -1024.6% | -215.3% | -117.1% | — | -33.5% | — |
| ROA | -35.6% | -35.6% | -66.2% | -64.1% | -46.6% | -34.6% | -31.7% |
| ROIC | -190.8% | -190.8% | -147.7% | — | — | — | — |
| ROCE | -73.0% | -73.0% | -60.8% | -63.6% | -55.8% | -40.2% | -38.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 6.09 | 0.17 | — | 0.04 | — |
| Debt / EBITDA | — | — | — | — | — | — | — |
| Net Debt / Equity | — | — | 2.85 | -0.49 | — | 0.04 | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | — | -6946.71 | -112.62 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.43 | 1.43 | 3.26 | 6.22 | 2.21 | 0.91 | 5.04 |
| Quick Ratio | 1.43 | 1.43 | 3.26 | 6.02 | 2.14 | -2.95 | 4.91 |
| Cash Ratio | 0.47 | 0.47 | 1.84 | 4.35 | 1.48 | 0.46 | 3.98 |
| Asset Turnover | — | 0.56 | 0.28 | 0.26 | 0.21 | 0.17 | 0.15 |
| Inventory Turnover | — | — | — | 8.42 | 6.79 | 5.25 | 5.94 |
| Days Sales Outstanding | — | 62.27 | 209.25 | 229.59 | 290.25 | 208.99 | 232.83 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | 81.6% | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | 0.0% | — |
| FCF Yield | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.9% | 0.7% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 82.4% | 0.7% | 0.0% | — |
| Shares Outstanding | — | $2M | $2M | $2M | $93020 | $187500 | $2M |
Liquidity and Dilution Risk
According to current market data, LanzaTech trades at a price-to-sales ratio of 0.27, which, when viewed alongside a negative trailing P/E of -0.31, suggests that investors are pricing the firm based on future platform optionality rather than any near-term ability to generate positive net income.
The lack of meaningful EV/EBITDA or P/B multiples reflects the market's difficulty in valuing a pre-profit synthetic biology firm that is currently in a heavy capital-expenditure phase. This valuation appears to hinge entirely on the successful scaling of its proprietary microbial technology, as traditional earnings-based metrics are currently non-functional for assessing the company's intrinsic value.
Based on reported figures, LanzaTech's ROIC has remained consistently negative, reaching -26.8% in 2026Q1, which indicates that the company is currently destroying shareholder capital rather than compounding it as it attempts to transition from laboratory-scale innovation to industrial-scale commercial deployment.
The persistent negative returns on invested capital suggest that the high costs associated with maintaining specialized microbial libraries and engineering support are not yet being offset by licensing revenue. Investors should monitor whether the company can achieve a positive ROIC as its plant backlog matures, though current trends indicate a significant structural hurdle to achieving profitability.
As reported in financial statements, the company's asset turnover ratio remains extremely low at 0.12 in 2026Q1, highlighting a significant inefficiency in converting the firm's specialized industrial assets into revenue compared to more established technology licensing peers in the broader industrial sector.
The extended DSO, which has fluctuated significantly, suggests that LanzaTech faces challenges in collecting payments from its industrial partners, potentially due to the milestone-based nature of its contracts. This inefficiency in working capital management exacerbates the company's cash burn, as the firm must fund its operations while waiting for project-based revenue to materialize.
According to recent quarterly filings, the current ratio has compressed from a high of 6.89 in 2024Q1 to 1.96 in 2026Q1, signaling a rapid depletion of the company's short-term liquidity buffer as it continues to fund its ongoing operational losses through existing cash reserves.
While a current ratio of 1.96 may appear adequate in isolation, the company's high cash burn rate suggests that this liquidity position is precarious and may not provide a sufficient cushion for unforeseen operational delays. The firm's reliance on external capital to sustain its current burn rate warrants close monitoring of potential dilutive financing events in the near term.
As evidenced by the company's business model, the P/S ratio is the most commonly misapplied metric, as it obscures the fact that LanzaTech's revenue is currently driven by lumpy, project-based engineering services rather than the high-margin, recurring licensing income that the market is likely attempting to price.
Investors should instead focus on the 'cumulative operational hours' of commercial plants and the conversion rate of MOUs into binding licensing agreements, as these metrics provide a more accurate picture of the company's long-term earning power. Relying on P/S multiples risks overestimating the stability of the firm's current revenue stream and underestimating the capital intensity required to reach a sustainable scale.
Includes 30+ ratios · 6 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LNZA stock.
LanzaTech Global, Inc.'s current P/E ratio is -0.3x. This places it at the 50th percentile of its historical range.
LanzaTech Global, Inc.'s return on equity (ROE) is -1024.6%. The historical average is -122.0%.
Based on historical data, LanzaTech Global, Inc. is trading at a P/E of -0.3x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
LanzaTech Global, Inc. has 45.3% gross margin and -141.7% operating margin.